Show results for
Refine by
Coronavirus Covid Equipment Supplied In Europe
5 equipment items found
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) ...
Manufactured by:Diatheva Srl based inCartoceto, ITALY
Coronaviruses are a large family of viruses that are common in people and many different species of animals including camels, cattle, cats, and bats. In December 2019, a cluster of patients with a novel coronavirus was identified in Wuhan, China. The virus named SARS-CoV-2 can cause the disease named coronavirus disease 2019 (COVID-2019) [WHO, ...
Manufactured by:G&N Medical based inHorsham, UNITED KINGDOM
In light of reduced incineration capacity in the market and the global need to reduce carbon footprint, G&N has worked with technical and engineering partners to provide solutions for clinics, hospitals and waste management companies. In the form of the Sterilsmart microwave and Bioenergy Vortex reformer treatment systems. Microwave technology for sterilisation of clinical waste, making its ...
Manufactured by:Dixion distribution of medical devices GmbH based inDüsseldorf, GERMANY
The kit is used to detect the neutralizing antibody to SARS-CoV-2 in human serum, plasma or whole blood sample quantitatively. It is mainly used to identify individuals with acquired immune response to the SARS-CoV-2, and to evaluate the effectiveness of the vaccine clinical trials and mass ...
Manufactured by:Labmaster Ltd. based inKAARINA, FINLAND
The Labmaster LUCIA™ SARS-CoV-2 IgG RBD test is meant for in vitro diagnostic qualitative detection of the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain IgG antibodies from whole blood samples in near-patient testing by measuring the immunochemical interaction between the Anti-SARS-CoV-2 immunoglobulin G (IgG) and the ...